Obesity Trial, Recruiting NCT05119868 Sponsor: Federico II University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05119868
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 20 to 35 years old who are healthy and in their first trimester of pregnancy
  • Women whose baby is considered at risk of developing allergic conditions (atopy)

Who may not be able to join:

  • People who currently have an active infection
  • People who currently have any form of cancer
  • People who have a major abnormality of the digestive system present at the same time
  • People who currently have a condition that weakens the immune system
  • People who currently have an autoimmune disease (where the immune system attacks the body)
  • People who currently have a chronic inflammatory bowel disease, such as Crohn's disease or ulcerative colitis
  • People who currently have a functional gastrointestinal disorder, such as irritable bowel syndrome (confirm with trial site)
  • People who currently have coeliac disease
  • People who have previously had surgery to remove part of the digestive tract
  • People who currently have a neurological or psychiatric condition
  • People who currently have a condition affecting the brain or central nervous system
  • People who follow a vegan diet
  • People who are carrying twins
  • People who currently have a genetic disorder
  • People who currently have a metabolic disorder, such as diabetes or thyroid conditions (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roberto Berni Canani, Department of Traslational Medical Science at University of Naples Federico II

Phone: 0817462680

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Federico II University
Registry
ClinicalTrials.gov
Start date
2 November 2021
Est. completion
10 January 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Occurrence of allergic disorders at 24 months of age in the offspring

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov